The largest database of trusted experimental protocols

Ultra low attachment flask

Manufactured by Corning
Sourced in United States

Ultra-low attachment flasks are a type of laboratory equipment designed to prevent cell attachment to the surface of the flask. These flasks feature a specialized coating that minimizes cell adhesion, allowing cells to grow in a suspension culture. This promotes the formation of spheroids, organoids, or other 3D cellular structures.

Automatically generated - may contain errors

66 protocols using ultra low attachment flask

1

Sphere Induction of Neural Progenitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were suspended in the sphere induction medium, which is based on neural stem cell medium. The basal medium for the sphere induction medium is DMEM/F12 (Sigma-Aldrich, Tokyo, Japan) supplemented with 10 mM HEPES (Sigma-Aldrich), 1× antibiotic-antimycotic solution (Sigma-Aldrich), 0.6% glucose (Sigma-Aldrich), 1 mg/mL transferrin, 250 μg/mL insulin (Sigma-Aldrich), 0.6 mM putrescine (Sigma-Aldrich), 0.3 μM sodium selenite (Sigma-Aldrich), and 0.2 μM progesterone (Sigma-Aldrich). Complete sphere induction medium was prepared by adding 2 μg/mL heparin (Sigma-Aldrich), 10 ng/mL human recombinant EGF (Sigma-Aldrich), 10 ng/mL bFGF (Merck Millipore, Tokyo, Japan), 10 ng/mL leukemia inhibitory factor (LIF, Merck Millipore), 60 μg/mL N-acetyl-L-cysteine (NAC, Sigma-Aldrich), and 1/50 vol. neural survival factor-1 (NSF-1, Lonza, Tokyo, Japan) to the basal medium. Briefly, cells were collected and washed to remove serum and then cultured in the sphere induction medium at 37°C in a humidified atmosphere of 5% CO2 in air. The next day, induction was begun, and floating cells were transferred into a hydrophilic ultra low attachment flask (Corning, Corning, NY).
+ Open protocol
+ Expand
2

Isolation and Differentiation of Breast Cancer Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
BCSCs were isolated from human breast cancer tissues obtained from patients as previously described34 (link) and were cultured in a selective medium34 (link) supplemented with 10 ng/ml βFGF (Peprotech, London, UK), 20 ng/ml EGF (Peprotech) to a final concentration 5 × 104/ml in ultra low attachment flask (Corning, New York, NY, USA) at 37 °C in a 5% (v/v) CO2 humidified chamber. BCSCs were induced to differentiate in order to obtain SDACs by culturing them in adherent condition in D-MEM with high glucose (Euroclone, Milan, Italy) supplemented with 10% (v/v) fetal bovine serum (Euroclone). The tumor s were histopathologically classified as follows: BCSC#1 is an invasive ductal carcinoma, grading G2, ER 90%, PR 60%, HER2/neu 3+ and ki67 >10% BCSC#2 is an invasive ductal carcinoma, grading G2, ER 90%, PR 60%, HER2/neu 3+ and ki67 25%, BCSC#3 is an invasive ductal carcinoma, grading G2, ER 80%, PR 80%, HER2/neu 3+ and ki67 >10%. HER2 status has been assigned according to the FDA guidelines.
+ Open protocol
+ Expand
3

Isolation and Characterization of Primary Breast Cancer Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human breast cancer sphere cells (BCSC) were obtained through mechanical and enzymatical digestion of breast cancer tissues, collected at the Department of Surgical, Oncological and Stomatological Sciences, in accordance with the ethical standards of the University of Palermo institutional committee, as previously described [38 (link)]. BCSCs were cultured in serum-free DMEM/F12 medium, supplemented with 2% B27 (50 ×, Gibco), basic fibroblast growth factor (bFGF; 10 ng/mL) and EGF (20 ng/mL) in ultra-low attachment flask (Corning). In these culture conditions the breast cancer cells grow as aggregates conventionally defined as “spheres”. In order to assess the presence of cancer stem cells in our BCSC population, BCSCs were characterized in terms of ALDH1 activity, and then subcutaneously injected in NOD/SCID mice to test their ability to form tumor xenografts [39 (link)].
+ Open protocol
+ Expand
4

Isolation and Culture of Mouse Pancreatic Islets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were anesthetized by a mixture of ketamine (Fujita Pharmaceutical Co., Ltd, Tokyo, Japan) and xylazine (Bayer Yakuhin, Ltd. Osaka, Japan). After laparotomy, the pancreas was distended with 2 ml of cold HBSS (Life Technologies, Carlsbad, CA) containing 1 000 U/ml of Collagenase-Yakult (Yakult Pharmaceutical Industry Co., Ltd, Tokyo, Japan) through the common bile duct, and subsequently excised and incubated in a stationary bath at 37 °C. Islets were separated by density gradients (Histopaque-1077; Sigma, St. Louis, MO, USA) and handpicked under a stereomicroscope. The isolated islets were cultured 24-36 h in RPMI1640 medium (Life Technologies, Carlsbad, CA, USA) with 10 % inactivated fetal bovine serum (FBS, Life Technologies) and antibiotics in an Ultra-Low Attachment flask (Corning Incorporated, New York, NY, USA) at 37 °C in a humidified air atmosphere containing 5 % CO 2 . The islets were used for further experiments and some of them were assigned to the non-vitrified group.
+ Open protocol
+ Expand
5

Cardiosphere-Derived Cardiac Stem Cell Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human CSCs were derived as previously descried using the cardiosphere
method.44 (link) In brief, heart tissues were
cut into tiny pieces and washed with PBS and digestion of collagenase
(Sigma, St. Louis, MO). Tissue fragments were cultured as “cardiac
explants” on a plate coated with 0.5 mg/mL fibronectin (BD
Biosciences, San Jose, CA) in IMDM supplemented with FBS, 0.5% gentamicin
(Gibco, Life Technologies, California, USA), 0.1 mM 2-mercaptoethanol
(Invitrogen), and 1% l-glutamine (Invitrogen). After about
7–14 days, we collected cardiac explanted-derived cells with
0.25% trypsin (Gibco) and then seeded them in ultralow attachment
flasks (Corning) for cardiospheres. After several days, cardiosphere-derived
cardiac stem cells were formed by seeding harvested cardiospheres
on fibronectin-coated plates and being incubated in 5% CO2 at 37 °C.
+ Open protocol
+ Expand
6

Isolation and Culture of Rat Cardiac Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We obtained rat CSCs from the hearts of WKY rats as described in previously published papers12 (link),26 (link),27 (link). Briefly, hearts were minced into fragments less than 2 mm3, followed by digestion with collagenase and then seeded onto fibronectin-coated plates to create explant-derived cells. In about 14 days, explant-derived cells were harvested and seeded in ultralow attachment flasks (Corning Life Sciences, Durham, NC) and grown in suspended culture for cardiosphere formation. CSCs were obtained by replating cardiospheres on fibronectin-coated plates.
+ Open protocol
+ Expand
7

Isolation and Culture of Pleural Effusion Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The first 8 pleural effusion samples were diluted 1:1 with Dulbecco′s modified eagle media (DMEM) low glucose (PAA Laboratories GmbH, Pasching, Austria), 10% fetal bovine serum (FBS gold PAA Laboratories GmbH, Pasching, Austria) and 2% antibiotic-antimycotic (ABAM Gibco, Thermo Fischer Scientific, MA, USA). The isolation procedure for samples PL13-25 was optimized, whereby the pleural effusion aspirates were filtered through a wide-meshed strainer at the beginning. The volume processed varied between 10 mL and 1500 mL, depending on the amount of the obtained material. After a centrifugation step at 400xg for 15 min, the cells were washed with phosphate buffer saline (PBS) and centrifuged at 800xg for 15 min. The cell suspension was treated with an ammonia lysis buffer for 5 minutes. After the lysis step, the cell suspension was filtrated through a 70 μm filter. Cells were counted, and a median number of 40.3*107 cells were transferred to culture (range: 4.3*106−3*109). Cells were seeded in ultra-low attachment flasks (Corning, New York, USA) and sphere formation assay was initiated. Alternatively, cells were seeded in adherent cell culture with DMEM low glucose, 10% FBS and 2% ABAM. The cells were grown at 37°C and 5% CO2 conditions.
+ Open protocol
+ Expand
8

Isolation and Characterization of Colorectal Cancer Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human CRC cell lines Colo205, SW480, HT29, SW620, LS174T, DLD1, Caco-2 were purchased from ATCC and cultured in RPMI-1640 medium. No mycoplasma contamination was detected. Human CCSCs were isolated and cultured as described previously (Bu et al., 2013 (link)). Briefly, CCSCs were isolated from patient tumors by FACS based on markers CD44, CD133 and ALDH1 and functionally validated by serial sphere formation, tumor initiation, and self-renewal assays. For this study, original frozen stocks for the first passage were used. The CCSCs have not been authenticated by STR profiling. No mycoplasma contamination was detected. CCSCs were cultured as spheres in ultralow-attachment flasks (Corning, Tewksgury, MA) in DMEM/F12 (Invitrogen, Pittsburgh, PA), supplemented with nonessential amino acids (Fisher, Pittsburgh, PA), sodium pyruvate (Fisher), Penicillin-streptomycin (Fisher), N2 supplement (Invitrogen), B27 supplement (Invitrogen), 4 μg/mL heparin (Sigma, Mendota Heights, MN), 40 ng/mL epidermal growth factor (Invitrogen), and 20 ng/mL basic fibroblast growth factor (Invitrogen) at 37°C and 5% CO2.
To measure tumor sphere formation, single CCSCs were plated in 24-well ultra-low attachment plates (Corning) at 1,000 cells per well. Tumor spheres were counted after 2 weeks in culture by an inverted microscope (Olympus).
+ Open protocol
+ Expand
9

Isolation and Polarization of Human Monocyte-Derived Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monocytes were isolated from enriched leukocyte fractions of human peripheral blood purchased from the New York Blood Center using sequential Ficoll and Percoll density gradient centrifugations, as we have previously described [21 (link)]. Monocytes were cultured at 37°C and 5% CO2 in ultra low attachment flasks (Corning) for five days at a density of 0.4×106 cells/cm2 and 1.0×106 cells/ml of complete media (RPMI media supplemented with 10% heat-inactivated human serum, 1% penicillin-streptomycin, and 20ng/ml macrophage colony stimulating factor (MCSF)). Macrophages were polarized over the next 1–6 days by culturing at 1.0×106 cells/ml in complete media with 100ng/ml IFN-gamma (Peprotech, Rocky Hill, NJ) and 100ng/ml lipopolysaccharide (LPS, Sigma Aldrich) for M1 or 40ng/ml IL4 and 20ng/ml IL13 (Peprotech, Rocky Hill, NJ) for M2, with a media change at day 3. At the media change, the media of another group of M1 macrophages was switched to M2-polarizing media and the media of a group of M2 macrophages was switched to M1-polarizing stimuli, in order to characterize the ability of macrophages to switch phenotypes. Unactivated macrophages were also cultured over the same time periods (M0), resulting in three groups through day 3 (M0, M1, M2) and five groups between days 4 and 6 (M0, M1, M2, M1→M2, M2→M1) (Fig. 1a).
+ Open protocol
+ Expand
10

Establishment of ZA-resistant PCa Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PCa cell line DU145 was purchased from American Type Culture Collection (Rockville, MD, USA). ZA-resistant DU145R80 cells were obtained by treating DU145 with increasing concentrations of ZA as previously described [9 (link)]. DU145 and DU145R80 cells were grown in RPMI 1640 (Lonza) containing 10% of heat-inactivated fetal bovine serum (FBS; Lonza), 10000 U/ml penicillin and 10 mg/ml streptomycin (Lonza), 20 mM Hepes (pH 7.4) and 4 mM L-glutamine. The cells were grown in a humidified atmosphere composed of 95% air and 5% CO2 at 37°C. Suspension culture was performed in Ultra-low attachment flasks (Corning Incorporated Life Sciences, Tewksbury, MA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!